Clinical Trial Update: Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral budesonide with oral mesalazine in active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mesalazine (mesalazine)
• budesonide (oral) (budesonide)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED